International Stem Cell Corp. (ISCO) Completes Conference Call on Q2 Financial Results
As promised, biotechnology company International Stem Cell Corp. held a conference call to discuss their Q2 financial results the company released earlier. The call was hosted by Simon Craw, ISCO’s Executive VP of Business Development, and Linh Nguyen, ISCO’s CFO. The financial figures, available in yesterday’s release, were summarized in the call by Linh Nguyen, and Simon Craw went over some of the associated events in addition to fielding questions from investors. One of the key points made related to a decrease in sales coming from Lifeline Cell Technology and Lifeline Skin Care. The products are not considered to be…